Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients

Drug and Alcohol Dependence

Volumn 169, Issue , 2016, Pages 41-47

  Cranford, James A ^a   Bohnert, Kipling M ^a,b   Perron, Brian E ^c   Bourque, Carrie ^a   Ilgen, Mark ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Correlates of cannabis vaping; Medical cannabis; Route of cannabis administration; Vaping

Indexed keywords

CENTRAL STIMULANT AGENT; MEDICAL CANNABIS;

ADULT; AGE DISTRIBUTION; ARTICLE; CANNABIS SMOKING; CANNABIS USE; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VAPING; VAPORIZATION; AGE; AGED; DRINKING BEHAVIOR; EPIDEMIOLOGY; MICHIGAN; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; MEDICAL MARIJUANA; MICHIGAN; MIDDLE AGED; PREVALENCE; VAPING; YOUNG ADULT;

EID: 84994357235     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.10.008     Document Type: Article

References (41)

1. Abrams, D.I., Jay, C.A., Shade, S.B., Vizoso, H., Reda, H., Press, S., Kelly, M.E., Rowbotham, M.C., Petersen, K.L., Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 68 (2007), 515–521.
2. Aggarwal, S.K., Cannabinergic pain medicine: a concise clinical primer and survey of randomized-controlled trial results. Clin. J. Pain 29 (2013), 162–171.
3. Agresti, A., Categorical Data Analysis. 3rd ed., 2013, John Wiley & Sons, Inc., Hoboken, NJ.
4. Arrazola, R.A., Singh, T., Corey, C.G., Husten, C.G., Neff, L.J., Apelberg, B.J., Bunnell, R.E., Choiniere, C.J., King, B.A., Cox, S., Tobacco use among middle and high school students – United States, 2011–2014. MMWR 64 (2015), 381–385.
5. Babor, T.F., Higgins-Biddle, J.C., Saunders, J.B., Monteiro, M.G., The Alcohol Use Disorders Identification Test: Guidelines For Use In Primary Care. 2nd ed., 2001, World Health Organization, Geneva, Switzerland.
6. Baggio, S., Deline, S., Studer, J., Mohler-Kuo, M., Daeppen, J.-B., Gmel, G., Routes of administration of cannabis used for nonmedical purposes and associations with patterns of drug use. J. Adolesc. Health 54 (2014), 235–240.
7. Benowitz, N.L., Emerging nicotine delivery products: implications for public health. Ann. Am. Thorac. Soc. 11 (2014), 231–235.
8. Borgelt, L.M., Franson, K.L., Nussbaum, A.M., Wang, G.S., The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 33 (2013), 195–209.
9. Borodovsky, J.T., Crosier, B.S., Lee, D.C., Sargent, J.D., Budney, A.J., Smoking, vaping, eating: is legalization impacting the way people use cannabis?. Int. J. Drug Policy 36 (2016), 141–147.
10. Budney, A.J., Sargent, J.D., Lee, D.C., Vaping cannabis (marijuana): parallel concerns to e-cigs?. Addiction 110 (2015), 1699–1704.
11. Compton, W.M., Han, B., Jones, C.M., Blanco, C., Hughes, A., Marijuana use and use disorders in adults in the USA, analysis of annual cross-sectional surveys. Lancet Psychiatry, 2016, 2002–2014 (epub ahead of print).
12. Cox, B., Can the research community respond adequately to the health risks of vaping?. Addiction 110 (2015), 1708–1709.
13. Earleywine, M., Barnwell, S.S., Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduct. J., 4, 2007, 11.
14. Etter, J.F., Electronic cigarettes and cannabis: an exploratory study. Eur. Addict. Res. 21 (2015), 124–130.
15. Fischer, B., Russell, C., Tyndall, M.W., Cannabis vaping and public health—some comments on relevance and implications. Addiction 110 (2015), 1705–1706.
16. Gaedeke, K., Medical Marihuana Act Statistical Report for Fiscal Year 2015 (pursuant to MCL 333.26426 (i) (1), (2), (3), (4) and (5))., 2016, Health Licensing Division, Bureau of Professional Licensing, Michigan Department of Licensing and Regulatory Affairs, Lansing, MI.
17. Gartner, C.E., Mull it over: cannabis vaporizers and harm reduction. Addiction 110 (2015), 1709–1710.
18. Hall, W., Degenhardt, L., Adverse health effects of non-medical cannabis use. Lancet 374 (2009), 1383–1391.
19. Hasin, D.S., Saha, T.D., Kerridge, B.T., Goldstein, R.B., Chou, S.P., Zhang, H., Jung, J., Pickering, R.P., Ruan, J., Smith, S.M., Huang, B., Grant, B.F., Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry 72 (2015), 1235–1242.
20. Hill, K.P., Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA 313 (2015), 2474–2483.
21. Hindocha, C., Freeman, T.P., Ferris, J.A., Lynskey, M.T., Winstock, A.R., No smoke without tobacco: a global overview of cannabis and tobacco routes of administration and their association with intention to quit. Front. Psychiatry, 2016 (epub ahead of print).
22. Ilgen, M.A., Bohnert, K., Kleinberg, F., Jannausch, M., Bohnert, A.S.B., Walton, M., Blow, F.C., Characteristics of adults seeking medical marijuana certification. Drug Alcohol Depend. 132 (2013), 654–659.
23. Johnston, L.D., O'Malley, P.M., Miech, R.A., Bachman, J.G., Schulenberg, J.E., Monitoring The Future National Survey Results On Drug Use, 1975–2015: Overview, Key Findings On Adolescent Drug Use. 2016, Institute for Social Research, The University of Michigan, Ann Arbor, MI.
24. Koppel, B.S., Brust, J.C.M., Fife, T., Bronstein, J., Youssof, S., Gronseth, G., Gloss, D., Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 82 (2014), 1556–1563.
25. Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S.O., Murphy, S., Responsible and controlled use: older cannabis users and harm reduction. Int. J. Drug Policy 26 (2015), 709–718.
26. Lee, D.C., Crosier, B.S., Borodovsky, J.T., Sargent, J.D., Budney, A.J., Online survey characterizing vaporizer use among cannabis users. Drug Alcohol Depend. 159 (2016), 227–233.
27. Lin, L.A., Ilgen, M.A., Jannausch, M., Bohnert, K.M., Comparing adults who use cannabis medically with those who use recreationally: results from a national sample. Addict. Behav. 61 (2016), 99–103.
28. Malouff, J.M., Rooke, S.E., Copeland, J., Experiences of marijuana-vaporizer users. Subst. Abuse 35 (2013), 127–128.
29. Michigan Medical Marihuana Act, Initiated law 1 of 2008. MCL §§ 333 (2008), 26421–26430.
30. Morean, M.E., Kong, G., Camenga, D.R., Cavallo, D.A., Krishnan-Sarin, S., High school students’ use of electronic cigarettes to vaporize cannabis. Pediatrics 136 (2015), 611–616.
31. National Conference of State Legislatures, State medical marijuana laws. 2016 (Retrieved from http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx 20 September 2016).
32. Pacula, R.L., Jacobson, M., Maksabedian, E.J., In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction 111 (2016), 973–980.
33. Pisinger, C., Døssing, M., A systematic review of health effects of electronic cigarettes. Prev. Med. 69 (2014), 248–260.
34. Schauer, G.L., King, B.A., Bunnell, R.E., Promoff, G., McAfee, T.A., Toking, vaping, and eating for health or fun: marijuana use patterns in adults U.S., 2014. Am. J. Prev. Med. 50 (2016), 1–8.
35. Tashkin, D.P., How beneficial is vaping cannabis to respiratory health compared to smoking?. Addiction 110 (2015), 1706–1707.
36. Van Dam, N.T., Earleywine, M., Pulmonary function in cannabis users: support for a clinical trial of the vaporizer. Int. J. Drug Policy 21 (2010), 511–513.
37. Volkow, N.D., Baler, R.D., Compton, W.M., Weiss, S.R.B., Adverse health effects of marijuana use. N. Engl. J. Med. 370 (2014), 2219–2227.
38. Wallace, M.S., Marcotte, T.D., Umlauf, A., Gouaux, B., Atkinson, J.H., Efficacy of inhaled cannabis on painful diabetic neuropathy. J. Pain 16 (2015), 616–627.
39. Walton, K.M., Abrams, D.B., Bailey, W.C., Clark, D., Connolly, G.N., Djordjevic, M.V., Eissenberg, T.E., Fiore, M.C., Goniewicz, M.L., Haverkos, L., Hecht, S.S., Henningfield, J.E., Hughes, J.R., Oncken, C.A., Postow, L., Rose, J.E., Wanke, K.L., Yang, L., Hatsukami, D.K., NIH electronic cigarette workshop: developing a research agenda. Nicotine Tob. Res. 17 (2015), 259–269.
40. Whiting, P.F., Wolff, R.F., Deshpande, S., et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313 (2015), 2456–2473.
41. Wilsey, B., Marcotte, T., Deutsch, R., Gouaux, B., Sakai, S., Donaghe, H., Low-dose vaporized cannabis significantly improves neuropathic pain. J. Pain 14 (2013), 136–148.